Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
tough to move billions of shares and more Dilution coming .
looking forward to reviewing margins , sales and cash flows . as well as how they are raising new capital . 400k came from somewhere- More Interest free loans maybe.
Codyco- Tell us all how debt comes off the books? It's called dilution . Huge dilution coming
Anyway you look at Divest Dilution is coming . 500k of those notes will be converted whether it's now or the company keeps kicking the can down the road . 2 billion shares are coming whether you want them or not.
Red- Just need cash flow and sales . But keep in mind this company is headed to 2 billion shares outstanding unless of course they do the Dreaded reverse stock split. Sales vs Dilution. Keep us up Red - you seem to know the inside game here .
Divest- What you respectfully are missing is big dilution is about to come. Please read the financials - all kinds of variable rate convertibles will be hitting soon- There will be 2 billion shares outstanding shortly. Transparency so to protect you and make all Investors understand what is coming. Dilution is coming whether you like it or believe it . Its right in the reports for all to read.
Restricted stock is just as dilutive as non restricted Red. We are here to help you understand.
No we do not disagree what is said on the court documents. Why do you ask that ? We just believe dilution will be coming and we are here to peel this onion back. We would like the BOD to step up and act like a real board.
We think it is always great to put legacy issues in the rear view mirror. ( Shreiber) But can someone help us with 400k in dilution - How did the company raise this money and why isn't the company disclosing this in an 8k? We want and demand transparency . They did not have 400k on their balance sheet. Anyone know? We could imagine another 100,000,000 in dilution. Who knows maybe even warrants as well. Shareholders demand to know.
Form 4 was filed - that is how we learned of it . We know massive dilution is right around the corner- How? because we read and will continue to read .
Beginning in the quarter ended June 30, 2019, we entered into a series of credit financing arrangements from financing institutions by pledging future accounts receivable. The proceeds from these credit agreements were used to pay the initial amount due under the Schreiber settlement agreement. As of June 30, 2019, we had drawn approximately $153,000 under these agreements. During the nine month period ended March 31, 2020, additional draws of approximately $116,000 occurred and payments of approximately $76,000 were made. As of March 31, 2020, approximately $174,000 remained outstanding on these loans. AlwaysRed- Tell us about these.
question was why did Mr. Darcy convert his preferreds to common? Not sure you know or you would tell us . and these are what worries us for more dilution:At March 31, 2020, $835,737 of the 2019 Variable Rate Convertible Notes were convertible into common stock beginning in the quarter ending June 30, 2020. Subsequent to March 31, 2020, we repaid outstanding principal amount of $335,000, plus accrued interest and prepayment penalties, under these 2019 Variable Rate Convertible Notes. 500k left = 100,000,000 mill shares of dilution or more . and there is much much more .
Money- that will be a huge win - we agree . Who put up the 400k and what did they get for it? What is the dilution so the shareholders have transparency- simple question. Was it another interest free loan? Was it a convertable? Help us Money .
We continue to dig and strive to help this board with transparent work. Looks like Schreiber was fired in 2016 and if you need to blame someone for your losses he seems to be a terrific target. We are only concerned with SNDD and how they continue to be or not to be transparent. We will continue to focus on sales, filings, disclosures and their business. Consider us your new best friend to help you guide through their maze of deals, exchange agreements, board financings, dilution and ACH financings. From Specials , thermometers, real estate, Financial services, Zonis,Centri, Wound Clot, 3rd party deals on PPE, Cannibas and of course their FDA approved needle device which seems like more litigation is on the way . How do they not pay their consultants and seller of the technology. We are here to find out.
We will call them this week- Thanks
TheeZ- very simple. Stop diluting and make sales . Stop the charades and concentrate on medical device sales. Stop the massive dilution. Who sold you the technology in Sept 2018 , Centri - where is it, Wound clot- where is it, "Specials"- what went so very wrong?, Authorized shares will be increased soon or there will be a disastrous reverse stock split. - MGMT- all eyes on u .
1.5 billion shares outstanding will be shortly reported and more dilution is coming . This is what our work is starting to tell us. Our estimates
We bought it and we love it. The question is who was supposed to receive the 450k from SNDD?
Granrok- Why is this company not selling their needle device? Waiting on FDA ? Why aren't they paying their consultants? Who sold them the technology? In September 2018, the Company acquired the exclusive license rights to certain medical device technology for $450,000, plus a broker’s fee of $17,500. Under the terms of the license agreement, the Company has paid $25,000 plus the first of a total twenty quarterly payments of $21,250. Any remaining payments become immediately payable upon the receipt of final approval by the FDA of devices related to the technology. Additionally, the Company agreed to pay a consulting fee of $1,000 per month for sixty months. The broker’s fee was paid through the issuance of 14 million shares of the Company’s common stock. The quarterly payments and the consulting fee have been suspended at the present time as the Company and the seller negotiate certain disputes related to representations made by the seller at the time the Company acquired the rights. The ultimate date and resolution of this negotiation cannot be estimated at this time. As a result, the Company has included all of the future payments under the original agreement as noncurrent in the accompanying March 31, 2020 and June 30, 2019 consolidated balance sheets.
looking forward to the 10k . Any chance the company puts it out early?
Granrok- We couldn't agree more with you .
MD Global- What have they done? Granrok- Did you call them?
We love companies that try to better the World- especially the ones that are transparent and care about all their shareholders .
love the specials - hope the sales take off with these better prices. They need a big order from their Sheriff friends.
these businesses have no information but you point out they still advertise them. We will be reporting more shortly.
Cowpie88- help us with revenues from Wound Clot, " Specials" , Zoni? What is this Centri system? Lots of businesses and now Marijuana . How many employees does this company have to handle all these businesses?
Not every little lawsuit needs to be filed ? guess your definition of little is 114 million shares of dilution. We can't find in any public document even the mention of these 2 lawsuits . Divest/Jelly- point us to these disclosures in the documents- they must be there.
This is from the 10q - Again do you know who the sellers are ?
The quarterly payments and the consulting fee have been suspended at the present time as the Company and the seller negotiate certain disputes related to representations made by the seller at the time the Company acquired the rights. THIS SELLER
THEE Z- Who was the seller?
payments suspended... Divest - What happened?
In September 2018, the Company acquired the exclusive license rights to certain medical device technology for $450,000, plus a broker’s fee of $17,500. Under the terms of the license agreement, the Company has paid $25,000 plus the first of a total twenty quarterly payments of $21,250. Any remaining payments become immediately payable upon the receipt of final approval by the FDA of devices related to the technology. Additionally, the Company agreed to pay a consulting fee of $1,000 per month for sixty months. The broker’s fee was paid through the issuance of 14 million shares of the Company’s common stock. The quarterly payments and the consulting fee have been suspended at the present time as the Company and the seller negotiate certain disputes related to representations made by the seller at the time the Company acquired the rights. The ultimate date and resolution of this negotiation cannot be estimated at this time. As a result, the Company has included all of the future payments under the original agreement as noncurrent in the accompanying March 31, 2020 and June 30, 2019 consolidated balance sheets.
Uber- Why hasn't the company paid their consultant?
so you owned at one time 3% of the company - today you own less than 7 tenths of 1% and declining .
Sony - We only care when it was disclosed- Transparency is what we strive for. When was it disclosed?
Sony- show us where it's old. Where in the filings is it?